Wednesday, December 10, 2003
Media Contact:
Lynn Closway
Mayo Clinic
480-301-4222
closway.lynn@mayo.edu
For Immediate Release - December 10, 2003
SCOTTSDALE, Ariz. - The Scottsdale City Council yesterday approved a proposal for development of a new biomedical research facility on Mayo Clinic's Scottsdale campus to house research laboratories for the Translational Genomics Research Institute (TGen), Mayo Clinic and other biomedical research entities.
Under the agreement, Hornaday Properties, a local real estate development firm, has offered a proposal to finance the construction of a 100,000 square-foot facility dedicated to biomedical research, including space for a new TGen initiative called the Center for Translational Drug Development (TD2), and shell space for research expansion and the Mayo Clinic Cancer Center.
TD2 will be a wholly owned subsidiary of TGen that is dedicated to translating genomics discoveries into advances in human health by developing new drugs for the prevention and treatment of cancer. TD2 will collaborate with TGen researchers and others in the biotech/pharmaceutical sector to design relevant preclinical studies that are driven by the clinical trial design, and arrange Phase-I clinical trials.
"This new facility represents an opportunity to greatly enhance our ongoing biomedical research collaboration with colleagues at TGen and other research groups," said Victor F. Trastek, M.D., chair, Board of Governors, Mayo Clinic in Scottsdale. "It also supports a critical component of our mission - supporting medical research that will help patients and ultimately lead to decreasing the burden of human disease." Trastek added that this project is a first step in expanding a research presence on Mayo Clinic's Scottsdale campus as outlined in its recently released 40-year Master Plan.
Although the details are still being finalized, the agreement is likely to involve a collaborative arrangement between Mayo, Hornaday Properties, TGen and the City of Scottsdale with the opportunity to lease space to other biomedical research entities.
"We look forward to working with Mayo Clinic in Scottsdale," said TGen COO Richard Love. "Our partnership with Mayo Clinic complements those existing ones we have now with the City of Phoenix and the state's three universities. Each in its own way strengthens TGen's ability to fulfill its mission."
Mayo Clinic is a private group practice of medicine dedicated to providing diagnosis and treatment of patient illnesses through a systematic focus on individual patient needs. As a leading academic medical center in the Southwest, Mayo Clinic focuses on providing specialty and surgical care in more than 66 disciplines at its outpatient facility in north Scottsdale and at Mayo Clinic Hospital. The 205-bed hospital is located at 56th Street and Mayo Boulevard (north of Bell Road) in northeast Phoenix, and provides inpatient care to support the medical and surgical specialties of the Clinic, which is located at 134th Street and Shea Boulevard in Scottsdale.
###
To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. MayoClinic.com is available as a resource for your health stories.
Learn more about becoming a patient at Mayo Clinic in the Patient & Visitor Guide.